表紙
市場調查報告書

週邊動脈疾病(PAD)的市場規模:各類型,全球機會分析與產業預測(2020年∼2027年)

Peripheral Artery Disease Market by Type : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 955608
出版日期 內容資訊 英文 229 Pages
商品交期: 2-3個工作天內
價格
週邊動脈疾病(PAD)的市場規模:各類型,全球機會分析與產業預測(2020年∼2027年) Peripheral Artery Disease Market by Type : Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2020年07月01日內容資訊: 英文 229 Pages
簡介

全球週邊動脈疾病的市場規模,2019年是35億2,477萬美金。該市場,預計從2020年至2027年之間以8.5%的年複合成長率成長,2027年達到57億1,512萬美元。老年人口的迅速增加與其伴隨的週邊動脈疾病的盛行率增加,產品核可的增加,週邊動脈疾病治療的良好償付方案,藥劑溶出性血管支架等先進治療產品的引進等要素,推動該市場成長。再加上週邊動脈疾病的高風險因素的糖尿病和患高血壓病的人口增加促進市場成長。但,產品的回收,血管再阻塞(治療後的週邊動脈疾病復發)等問題妨礙市場成長。

本報告提供全球週邊動脈疾病市場的相關調查,市場機會,成長及阻礙因素,各類型、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 2019年的成功策略
  • 主要企業的地位
    • 主要的投資品牌
  • 週邊動脈疾病產業
    • 成長要素
      • 老年人口的增加和週邊動脈疾病的盛行率增加
      • 先進的介入產品的簡介
      • 新興各國的醫療保健基礎設施的改善
      • 保險和償付方針的改善
    • 阻礙因素
      • 血管再阻塞
      • 支架的嚴格核准流程
    • 市場機會
      • 新興各國的市場機會
    • 影響分析
  • COVID-19對市場的影響

第4章 市場分析:各類型

  • 概況
    • 市場規模、預測
  • 末梢血管成形術用氣球
    • 市場規模、預測
    • 傳統/傳統球囊
    • 削球、球囊導管
    • 藥物塗層球囊
  • 末梢支架
    • 市場規模、預測
    • 自我擴張
    • 球囊擴張
    • 覆膜支架
    • 藥物釋放型性支架
  • 末梢導管
    • 市場規模、預測
    • 血管造影術導管
    • 誘導導管
  • 下腔靜脈(IVC)過濾器
    • 市場規模、預測
    • 永久型過濾器
    • 可回收型過濾器
  • 斑塊修正設備
    • 市場規模、預測
    • 血栓切除設備
    • 旋切術設備
  • 血流改變設備
    • 市場規模、預測
    • 栓塞保護裝置
    • 慢性完全閉塞設備
  • 週邊設備
    • 市場規模、預測
    • 末稍血管封閉設備
    • 引進用鞘套
    • 導管導引線
    • 球囊充氣設備

第5章 市場分析:各地區

  • 概況
    • 市場規模與預測:各地區
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 其他
  • 南美、中東、非洲
    • 巴西
    • 南非
    • 沙烏地阿拉伯
    • 其他

第6章 企業簡介

  • ABBOTT LABORATORIES
  • ANGIODYNAMICS, INC.
  • B. BRAUN MELSUNGEN AG
  • BIOTRONIK, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • BECTON, DICKINSON AND COMPANY
  • CARDINAL HEALTH, INC.
  • COOK MEDICAL, INC.
  • KONINKLIJKE PHILIPS N.V. (PHILIPS)
  • Terumo Corporation
目錄
Product Code: A03968

Title:
Peripheral Artery Disease Market by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Peripheral Accessories): Global Opportunity Analysis and Industry Forecast, 2020-2027.

The global peripheral artery disease market accounted for $3,524.77 million in 2019, and is expected to reach $5,715.12 million by 2027, registering a CAGR of 8.5% from 2020 to 2027.

Peripheral artery disease (PAD) is a disease of blood vessels located outside the brain and heart. PAD occurs when plaque builds up in arteries that carry blood to the head, organs, and limbs. Plaque is made of fat, cholesterol, calcium, fibrous tissue, and other substances. PAD usually affects arteries in the legs, but it can also affect arteries that carry blood from heart to head, arms, kidneys, and stomach.

Factors such as rapid growth in geriatric population and subsequent increase in prevalence of peripheral artery diseases, along with increase in product approvals drive growth of the peripheral artery disease market. However, product recalls and hamper the market growth. Furthermore, increase in incidences of population suffering from diabetes and high blood pressure, which poses a high-risk factor for peripheral artery disease drives the market growth. In addition, favorable reimbursement scenario for peripheral artery disease treatment and introduction of advanced treatment products such as drug-eluting stents boost the market growth. However, issue of restenosis (reoccurrence of peripheral artery disease even after treatment) impedes the market growth.

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to factors such as well-equipped & better financed hospitals & clinics, high adoption rate of peripheral artery disease products, and sophisticated healthcare infrastructure. Moreover, the U.S. is the target area for top players in the market, owing to high awareness regarding PAD devices. However, Asia-Pacific and LAMEA are expected to emerge as a lucrative areas with maximum growth potential, owing to improvement in healthcare facilities, available disposable income, and rapidly developing economic conditions.

The global peripheral artery disease market is segmented on the basis of type and region. On the basis of type, the market is divided into peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. By region, the market is studied across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, India, China, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA)

The key companies operating in the market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Cardinal Health, Inc., Becton, Dickinson and Company, Terumo Corporation, Koninklijke Philips N.V, AngioDynamics, Inc., BIOTRONIK, and B. Braun Melsungen AG.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities.

The key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By type

  • Peripheral Angioplasty Balloons
  • Old/Normal Balloons
  • Cutting and Scoring Balloons
  • Drug-Coated Balloons
  • Peripheral Stents
  • Self-expandable
  • Balloon-expandable
  • Covered
  • Drug-eluting Stents
  • Peripheral Catheters
  • Angiography Catheters
  • Guiding Catheters
  • Inferior Vena Cava (IVC) Filters
  • Permanent Filters
  • Retrievable Filters
  • Plaque Modification Devices
  • Thrombectomy Devices
  • Mechanical Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Rheolytic Thrombectomy Devices
  • Atherectomy Devices
  • Hemodynamic Flow Alteration Devices
  • Embolic Protection Devices
  • Chronic Total Occlusion Devices
  • Peripheral Accessories
  • Vascular Closure Devices
  • Introducer Sheaths
  • Guidewires
  • Balloon Inflation Devices

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Abbott Laboratories
  • AngioDynamics
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BIOTRONIK
  • Cook Medical
  • Cardinal Health, Inc.
  • Koninklijke Philips N.V
  • TERUMO CORPORATION.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
    • 1.2.1.List of key players profiled in the report
  • 1.3.Research methodology
    • 1.3.1.Primary research
    • 1.3.2.Secondary research
    • 1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Top winning strategies, 2019
  • 3.3.Top player positioning
    • 3.3.1.Top investment pockets
  • 3.4.Key forces shaping peripheral artery disease industry/market
    • 3.4.1.Drivers
      • 3.4.1.1.Growth in geriatric population and increase in prevalence of peripheral artery disease
      • 3.4.1.2.Introduction of advanced interventional products
      • 3.4.1.3.Improvement of healthcare infrastructure in developing countries
      • 3.4.1.4.Improved insurance and reimbursement policies
    • 3.4.2.Restraints
      • 3.4.2.1.Restenosis
      • 3.4.2.2.Stringent approval process for stents
    • 3.4.3.Opportunity
      • 3.4.3.1.Market opportunities in developing countries
    • 3.4.4.Impact Analysis
  • 3.5.COVID-19 impact on the market

CHAPTER 4:PERIPHERAL ARTERY DISEASE MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast, by type
  • 4.2.Peripheral Angioplasty Balloons
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
    • 4.2.4.Peripheral angioplasty balloons, by type
      • 4.2.4.1.Market size and forecast
      • 4.2.4.2.Old/normal balloons, market size and forecast
      • 4.2.4.3.Cutting & scoring balloons, market size and forecast
      • 4.2.4.4.Drug-coated balloons, market size and forecast
  • 4.3.Peripheral Stents
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country
    • 4.3.4.Peripheral stent, by type
      • 4.3.4.1.Market size and forecast
      • 4.3.4.2.Self-expandable, market size and forecast
      • 4.3.4.3.Balloon-expandable, market size and forecast
      • 4.3.4.4.Covered stents, market size and forecast
      • 4.3.4.5.Drug-eluting stents, market size and forecast
  • 4.4.Peripheral Catheters
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country
    • 4.4.4.Peripheral catheters, by type
      • 4.4.4.1.Market size and forecast
      • 4.4.4.2.Angiography catheters, market size and forecast
      • 4.4.4.3.Guiding catheters, market size and forecast
  • 4.5.Inferior Vena Cava (IVC) Filters
    • 4.5.1.Key market trends, growth factors, and opportunities
    • 4.5.2.Market size and forecast, by region
    • 4.5.3.Market analysis, by country
    • 4.5.4.Inferior vena cava (IVC) filters, by type
      • 4.5.4.1.Market size and forecast
      • 4.5.4.2.Permanent filters, market size and forecast
      • 4.5.4.3.Retrievable filters, market size and forecast
  • 4.6.Plaque Modification Devices
    • 4.6.1.Key market trends, growth factors, and opportunities
    • 4.6.2.Market size and forecast, by region
    • 4.6.3.Market analysis, by country
    • 4.6.4.Plaque modification devices, by type
      • 4.6.4.1.Market size and forecast
      • 4.6.4.2.Thrombectomy devices, market size and forecast
      • 4.6.4.3.Thrombectomy devices, By type
      • 4.6.4.4.Thrombectomy devices, market size and forecast, by type
      • 4.6.4.4.1.Mechanical thrombectomy devices, market size and forecast
      • 4.6.4.4.2.Aspiration thrombectomy devices, market size and forecast
      • 4.6.4.4.3.Rheolytic thrombectomy devices, market size and forecast
      • 4.6.4.5.Atherectomy devices, market size and forecast
  • 4.7.Hemodynamic Flow Alteration Devices
    • 4.7.1.Key market trends, growth factors, and opportunities
    • 4.7.2.Market size and forecast, by region
    • 4.7.3.Market analysis, by country
    • 4.7.4.Hemodynamic flow alteration devices, By type
      • 4.7.4.1.Market size and forecast
      • 4.7.4.2.Embolic protection devices, market size and forecast
      • 4.7.4.3.Chronic total occlusion devices, market size and forecast
  • 4.8.Peripheral Accessories
    • 4.8.1.Key market trends, growth factors, and opportunities
    • 4.8.2.Market size and forecast, by region
    • 4.8.3.Market analysis, by country
    • 4.8.4.Peripheral Accessories, By type
      • 4.8.4.1.Market size and forecast
      • 4.8.4.2.Peripheral vascular closure devices, market size and forecast
      • 4.8.4.3.Introducer sheaths, market size and forecast
      • 4.8.4.4.Guidewires, market size and forecast
      • 4.8.4.5.Balloon inflation devices, market size and forecast

CHAPTER 5:PERIPHERAL ARTERY DISEASE MARKET, BY REGION

  • 5.1.Overview
    • 5.1.1.Market size and forecast, by region
  • 5.2.North America
    • 5.2.1.Key market trends, growth factors, and opportunities
    • 5.2.2.Market size and forecast, by country
    • 5.2.3.Market size and forecast, by type
    • 5.2.4.U.S.
    • 5.2.5.Canada
    • 5.2.6.Mexico
  • 5.3.Europe
    • 5.3.1.Key market trends, growth factors, and opportunities
    • 5.3.2.Market size and forecast, by country
    • 5.3.3.Market size and forecast, by type
    • 5.3.4.Germany
    • 5.3.5.France
    • 5.3.6.UK
    • 5.3.7.Italy
    • 5.3.8.Spain
    • 5.3.9.Rest of Europe
  • 5.4.Asia-Pacific
    • 5.4.1.Key market trends, growth factors, and opportunities
    • 5.4.2.Market size and forecast, by country
    • 5.4.3.Market size and forecast, by type
    • 5.4.4.Japan
    • 5.4.5.China
    • 5.4.6.India
    • 5.4.7.Australia
    • 5.4.8.Rest of Asia-Pacific
  • 5.5.LAMEA
    • 5.5.1.Key market trends, growth factors, and opportunities
    • 5.5.2.Market size and forecast, by country
    • 5.5.3.Market size and forecast, by type
    • 5.5.4.Brazil
    • 5.5.5.South Africa
    • 5.5.6.Saudi Arabia
    • 5.5.7.Rest of LAMEA

CHAPTER 6:COMPANY PROFILES

  • 6.1.ABBOTT LABORATORIES
    • 6.1.1.Company overview
    • 6.1.2.Company snapshot
    • 6.1.3.Operating business segments
    • 6.1.4.Product portfolio
    • 6.1.5.Business performance
  • 6.2.ANGIODYNAMICS, INC.
    • 6.2.1.Company overview
    • 6.2.2.Company snapshot
    • 6.2.3.Operating business segments
    • 6.2.4.Product portfolio
    • 6.2.5.Business performance
    • 6.2.6.Key strategic moves and developments
  • 6.3.B. BRAUN MELSUNGEN AG
    • 6.3.1.Company overview
    • 6.3.2.Company snapshot
    • 6.3.3.Operating business segments
    • 6.3.4.Product portfolio
    • 6.3.5.Business performance
  • 6.4.BIOTRONIK, INC.
    • 6.4.1.Company overview
    • 6.4.2.Company snapshot
    • 6.4.3.Operating business segments
    • 6.4.4.Product portfolio
    • 6.4.5.Key strategic moves and developments
  • 6.5.BOSTON SCIENTIFIC CORPORATION
    • 6.5.1.Company overview
    • 6.5.2.Company snapshot
    • 6.5.3.Operating business segments
    • 6.5.4.Product Portfolio
    • 6.5.5.Business performance
  • 6.6.BECTON, DICKINSON AND COMPANY
    • 6.6.1.Company overview
    • 6.6.2.Company snapshot
    • 6.6.3.Operating business segments
    • 6.6.4.Product portfolio
    • 6.6.5.Business performance
    • 6.6.6.Key strategic moves and developments
  • 6.7.CARDINAL HEALTH, INC.
    • 6.7.1.Company overview
    • 6.7.2.Company snapshot
    • 6.7.3.Operating business segments
    • 6.7.4.Product portfolio
    • 6.7.5.Business performance
  • 6.8.COOK MEDICAL, INC.
    • 6.8.1.Company overview
    • 6.8.2.Company snapshot
    • 6.8.3.Operating business segments
    • 6.8.4.Product portfolio
    • 6.8.5.Key strategic moves and developments
  • 6.9.KONINKLIJKE PHILIPS N.V. (PHILIPS)
    • 6.9.1.Company overview
    • 6.9.2.Company snapshot
    • 6.9.3.Operating business segments
    • 6.9.4.Product portfolio
    • 6.9.5.Business performance
    • 6.9.6.Key strategic moves and developments
  • 6.10.TERUMO CORPORATION
    • 6.10.1.Company overview
    • 6.10.2.Company snapshot
    • 6.10.3.Operating business segments
    • 6.10.4.Product portfolio
    • 6.10.5.Business performance
    • 6.10.6.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 02.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ANGIOPLASTY BALLOONS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 03.PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 04.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL STENTS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 05.PERIPHERAL CATHETERS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 06.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL CATHETER, BY REGION, 2019-2027 ($MILLION)
  • TABLE 07.PERIPHERAL CATHETERS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 08.PERIPHERAL ARTERY DISEASE MARKET FOR INFERIOR VENA CAVA (IVC) FILTERS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 09.INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 10.PERIPHERAL ARTERY DISEASE MARKET FOR PLAQUE MODIFICATION DEVICES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 12.PERIPHERAL ARTERY DISEASE MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 13.HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 14.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ACCESSORIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 15.PERIPHERAL ACCESSORIES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 16.PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 17.NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 18.NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 19.U.S. PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 20.CANADA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 21.MEXICO PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 22.EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 23.EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 24.GERMANY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 25.FRANCE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 26.UK PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 27.ITALY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 28.SPAIN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 29.REST OF EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 30.ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 31.ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 32.JAPAN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 33.CHINA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 34.INDIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 35.AUSTRALIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 36.REST OF ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 37.LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 38.LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 39.BRAZIL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 40.SOUTH AFRICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 41.SAUDI ARABIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 42.REST OF LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 43.ABBOTT: COMPANY SNAPSHOT
  • TABLE 44.ABBOTT: OERATING SEGMENT
  • TABLE 45.ABBOTT: PRODUCT PORTFOLIO
  • TABLE 46.ANGIODYNAMICS: COMPANY SNAPSHOT
  • TABLE 47.ANGIODYNAMICS: OPERATING SEGMENTS
  • TABLE 48.ANGIODYNAMICS: PRODUCT PORTFOLIO
  • TABLE 49.B. BRAUN: COMPANY SNAPSHOT
  • TABLE 50.B. BRAUN: OPERATING SEGMENTS
  • TABLE 51.B. BRAUN: PRODUCT PORTFOLIO:
  • TABLE 52.BIOTRONIK, INC..: COMPANY SNAPSHOT
  • TABLE 53.BIOTRONIK, INC..: OPERATING SEGMENTS
  • TABLE 54.BIOTRONIK, INC.: PRODUCT PORTFOLIO
  • TABLE 55.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 56.BOSTON SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 57.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 58.BD: SNAPSHOT
  • TABLE 59.BD: OPERATING SEGMENTS
  • TABLE 60.BD: PRODUCT PORTFOLIO
  • TABLE 61.CARDINAL HEALTH: COMPANY SNAPSHOT
  • TABLE 62.CARDINAL HEALTH: OPERATING SEGMENTS
  • TABLE 63.CARDINAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 64.COOK: COMPANY SNAPSHOT
  • TABLE 65.COOK: OERATING SEGMENT
  • TABLE 66.COOK: PRODUCT PORTFOLIO
  • TABLE 67.PHILIPS: COMPANY SNAPSHOT
  • TABLE 68.PHILIPS: OPERATING SEGMENTS
  • TABLE 69.PHILIPS: PRODUCT PORTFOLIO
  • TABLE 70.TERUMO: COMPANY SNAPSHOT
  • TABLE 71.TERUMO: OPERATING SEGMENTS
  • TABLE 72.TERUMO: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.PERIPHERAL ARTERY DISEASE MARKET SEGMENTATION
  • FIGURE 02.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2018-2020*
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2020*
  • FIGURE 04.TOP WINNING STRATEGIES: COMPANY, 2018-2020
  • FIGURE 05.TOP PLAYER POSITIONING, 2019
  • FIGURE 06.TOP INVESTMENT POCKETS
  • FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 08.HIGH BARGAINING POWER OF BUYERS
  • FIGURE 09.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 10.HIGH INTENSITY OF RIVALRY
  • FIGURE 11.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 12.IMPACT ANALYSIS, PERIPHERAL ARTERY DISEASE MARKET
  • FIGURE 13.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ANGIOPLASTY BALLOONS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 14.GLOBAL OLD/NORMAL BALLOONS MARKET, 2019-2027 ($MILLION)
  • FIGURE 15.GLOBAL CUTTING & SCORING BALLOONS MARKET, 2019-2027 ($MILLION)
  • FIGURE 16.GLOBAL DRUG COATED BALLOONS MARKET, 2019-2027 ($MILLION)
  • FIGURE 17.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL STENTS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 18.GLOBAL SELF-EXPANDABLE MARKET, 2019-2027 ($MILLION)
  • FIGURE 19.GLOBAL BALLOON EXPANDABLE MARKET, 2019-2027 ($MILLION)
  • FIGURE 20.GLOBAL COVERED STENTS MARKET, 2019-2027 ($MILLION)
  • FIGURE 21.GLOBAL DRUG-ELUTING STENTS MARKET, 2019-2027 ($MILLION)
  • FIGURE 22.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL CATHETER, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 23.GLOBAL ANGIOGRAPHY CATHETERS MARKET, 2019-2027 ($MILLION)
  • FIGURE 24.GLOBAL GUIDING CATHETERS MARKET, 2019-2027 ($MILLION)
  • FIGURE 25.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR INFERIOR VENA CAVA (IVC) FILTERS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 26.GLOBAL PERMANENT FILTERS MARKET, 2019-2027 ($MILLION)
  • FIGURE 27.GLOBAL RETRIEVABLE FILTERS MARKET, 2019-2027 ($MILLION)
  • FIGURE 28.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PLAQUE MODIFICATION DEVICES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 29.GLOBAL THROMBECTOMY DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 30.GLOBAL THROMBECTOMY DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • FIGURE 31.GLOBAL THROMBECTOMY DEVICES MARKET FOR MECHANICAL THROMBECTOMY DEVICES, BY TYPE 2019-2027 ($MILLION)
  • FIGURE 32.GLOBAL THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, BY TYPE 2019-2027 ($MILLION)
  • FIGURE 33.GLOBAL THROMBECTOMY DEVICES MARKET FOR RHEOLYTIC THROMBECTOMY DEVICES, BY TYPE, 2019-2027 ($MILLION)
  • FIGURE 34.GLOBAL ATHERECTOMY DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 35.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 36.GLOBAL EMBOLIC PROTECTION DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 37.GLOBAL CHRONIC TOTAL OCCLUSION DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 38.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ACCESSORIES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 39.GLOBAL PERIPHERAL VASCULAR CLOSURE DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 40.GLOBAL INTRODUCER SHEATHS MARKET, 2019-2027 ($MILLION)
  • FIGURE 41.GLOBAL GUIDEWIRES MARKET, 2019-2027 ($MILLION)
  • FIGURE 42.GLOBAL BALLOON INFLATION DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 43.ABBOTT: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 44.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 45.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 46.ANGIODYNAMICS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 47.ANGIODYNAMICS: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 48.ANGIODYNAMICS: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 49.B. BRAUN: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 50.B. BRAUN: REVENUE SHARE, BY SEGMENTS, 2019 (%)
  • FIGURE 51.B. BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 52.BOSTON SCIENTIFIC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 53.BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2019 (%)
  • FIGURE 54.BOSTON SCIENTIFIC: NET SALES, BY REGION, 2019 (%)
  • FIGURE 55.BD: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 56.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 57.BECTON, DICKINSON AND COMPANY REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 58.CARDINAL HEALTH: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 59.CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 60.CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 61.PHILIPS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 62.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 63.PHILIPS: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 64.TERUMO CORPORATION: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 65.TERUMO: REVENUE SHARE, BY SEGMENTS, 2018(%)
  • FIGURE 66.TERUMO: REVENUE SHARE, BY REGION, 2018 (%)